The ICM podcast series highlights research within the ICM programme in conversation with its members.
In this fourth of the series Duncan Jodrell discusses the MFICM supported ATRiUM clinical trial for pancreatic cancer.
March 8, 2021
The ICM podcast series highlights research within the ICM programme in conversation with its members.
In this fourth of the series Duncan Jodrell discusses the MFICM supported ATRiUM clinical trial for pancreatic cancer.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
